Why the study?
Does propafenone affect left ventricular ejection fraction in patients with congestive heart failure?
Does propafenone affect left ventricular ejection fraction in patients with congestive heart failure?
Answers are grounded in this paper and cite their sources.
Propafenone causes a modest decrease in left ventricular ejection fraction, particularly in patients with initially low ejection fractions, warranting caution in heart failure patients.
The effects of propafenone on left ventricular function and hemodynamics are presented in this study. In one group of 13 patients who underwent electrophysiological testing and subsequent chronic oral therapy with propafenone, eight had left ventricular ejection fractions determined by nuclear study before and during therapy with the drug. Initial measurements ranged from 22% to 39% (mean 30%), while those on chronic therapy showed no statistical difference and ranged from 22% to 48% (mean 30%). In a separate dose titration study of 14 patients, left ventricular ejection fraction showed a modest but significant decrease (52%± 9% to 48%± 11%; p < 0.05). This change was more marked in patients with an initial low ejection fraction. Propafenone appears to be safe in these patients but should be administered with caution in patients with particularly low ejection fractions.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: